Has2 (hyaluronan synthase 2) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Has2 (hyaluronan synthase 2) Rattus norvegicus
Symbol: Has2
Name: hyaluronan synthase 2
RGD ID: 2781
Description: Enables hyaluronan synthase activity. Involved in several processes, including estrous cycle; hyaluronan biosynthetic process; and positive regulation of cell migration. Predicted to be located in several cellular components, including Golgi apparatus; extracellular vesicle; and plasma membrane raft. Biomarker of diabetes insipidus; middle cerebral artery infarction; and pulmonary hypertension. Orthologous to human HAS2 (hyaluronan synthase 2); INTERACTS WITH 17beta-estradiol; 2,3,7,8-tetrachlorodibenzodioxine; 3,3',4,4',5-pentachlorobiphenyl.
Type: protein-coding
Previously known as: HA synthase 2; hyaluronate synthase 2; hyaluronic acid synthase 2
RGD Orthologs
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: Has2m1Mcwi  
Genetic Models: BN-Has2m1Mcwi
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2788,113,326 - 88,139,337 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl788,113,326 - 88,128,933 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx789,997,804 - 90,023,812 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0792,199,040 - 92,225,048 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0792,001,677 - 92,027,674 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0796,438,046 - 96,464,049 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl796,438,046 - 96,464,049 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0797,055,458 - 97,081,461 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4793,230,135 - 93,256,139 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1793,264,364 - 93,290,369 (-)NCBI
Celera784,901,996 - 84,927,998 (-)NCBICelera
RH 3.4 Map7607.6RGD
Cytogenetic Map7q33NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
1,2-dimethylhydrazine  (ISO)
1,4-phenylenediamine  (ISO)
1-chloro-2,4-dinitrobenzene  (ISO)
15-acetyldeoxynivalenol  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',5,5'-tetrachlorobiphenyl  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP)
2-palmitoylglycerol  (ISO)
3,3',4,4',5-pentachlorobiphenyl  (EXP)
3,4-dichloroaniline  (ISO)
4,4'-sulfonyldiphenol  (ISO)
4-nonylphenol  (ISO)
4-tert-Octylphenol  (ISO)
5-aza-2'-deoxycytidine  (ISO)
6-propyl-2-thiouracil  (EXP)
7,12-dimethyltetraphene  (ISO)
8-Br-cAMP  (ISO)
acetamide  (EXP)
acrylamide  (EXP)
aflatoxin B1  (ISO)
all-trans-retinoic acid  (ISO)
ammonium chloride  (EXP)
antirheumatic drug  (ISO)
aristolochic acid A  (ISO)
arsane  (ISO)
arsenic atom  (ISO)
arsenite(3-)  (ISO)
arsenous acid  (ISO)
benzo[a]pyrene  (ISO)
benzo[a]pyrene diol epoxide I  (ISO)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
bisphenol F  (ISO)
buta-1,3-diene  (ISO)
butylated hydroxyanisole  (ISO)
cadmium atom  (ISO)
cadmium dichloride  (ISO)
calcitriol  (ISO)
cannabidiol  (ISO)
carbon nanotube  (ISO)
cisplatin  (ISO)
copper atom  (ISO)
copper(0)  (ISO)
crocidolite asbestos  (ISO)
cytarabine  (ISO)
dexamethasone  (ISO)
diallyl trisulfide  (ISO)
diarsenic trioxide  (ISO)
dibutyl phthalate  (EXP)
dioxygen  (ISO)
diuron  (ISO)
dorsomorphin  (ISO)
doxorubicin  (ISO)
enalapril  (EXP)
fluoranthene  (ISO)
formaldehyde  (ISO)
fulvestrant  (ISO)
genistein  (ISO)
glutathione  (ISO)
glycidol  (EXP)
hyaluronic acid  (ISO)
hydrogen peroxide  (ISO)
ketoconazole  (ISO)
methylisothiazolinone  (ISO)
methylmercury chloride  (ISO)
methylparaben  (ISO)
mono(2-ethylhexyl) phthalate  (ISO)
Monobutylphthalate  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
N-acetyl-L-cysteine  (ISO)
oxaliplatin  (EXP)
oxytocin  (EXP)
ozone  (ISO)
p-tert-Amylphenol  (ISO)
panobinostat  (ISO)
PCB138  (ISO)
PD 0325901  (ISO)
pentane-2,3-dione  (EXP)
perfluorohexanesulfonic acid  (ISO)
potassium chromate  (ISO)
raloxifene  (ISO)
SB 203580  (ISO)
SB 431542  (ISO)
serpentine asbestos  (ISO)
silver atom  (ISO)
silver(0)  (ISO)
sodium arsenate  (ISO)
sodium arsenite  (ISO)
T-2 toxin  (ISO)
tamoxifen  (ISO)
tert-butyl hydroperoxide  (ISO)
testosterone  (EXP)
tetrachloromethane  (ISO)
thioacetamide  (EXP)
titanium dioxide  (ISO)
topotecan  (EXP)
trichloroethene  (EXP)
trichostatin A  (ISO)
triptonide  (ISO)
tyrphostin AG 1478  (EXP)
valproic acid  (ISO)
vorinostat  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Cellular Component

Molecular Function


References - curated
# Reference Title Reference Citation
1. Synthesis and fragmentation of hyaluronan in renal ischaemia. Decleves AE, etal., Nephrol Dial Transplant. 2012 Oct;27(10):3771-81. doi: 10.1093/ndt/gfs098. Epub 2012 Apr 23.
2. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
3. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
4. Parallel up-regulation of FGF-2 and hyaluronan during development of cardiac hypertrophy in rat. Hellman U, etal., Cell Tissue Res. 2008 Jan 15;.
5. CRISPR/Cas9 knockout of HAS2 in rat chondrosarcoma chondrocytes demonstrates the requirement of hyaluronan for aggrecan retention. Huang Y, etal., Matrix Biol. 2016 Dec;56:74-94. doi: 10.1016/j.matbio.2016.04.002. Epub 2016 Apr 14.
6. Expression of type II hyaluronan-synthase gene in kidneys Wistar and Brattleboro rats with diabetes insipidus: effect of vasopressin and its analogues. Kabilova NO, etal., Dokl Biochem Biophys. 2009 Mar-Apr;425:61-4.
7. High-density rat radiation hybrid maps containing over 24,000 SSLPs, genes, and ESTs provide a direct link to the rat genome sequence. Kwitek AE, etal., Genome Res. 2004 Apr;14(4):750-7
8. Rat ISS GO annotations from MGI mouse gene data--August 2006 MGD data from the GO Consortium
9. Electronic Transfer of LocusLink and RefSeq Data NCBI rat LocusLink and RefSeq merged data July 26, 2002
10. The enzymatic degradation of hyaluronan is associated with disease progression in experimental pulmonary hypertension. Ormiston ML, etal., Am J Physiol Lung Cell Mol Physiol. 2010 Feb;298(2):L148-57. doi: 10.1152/ajplung.00097.2009. Epub 2009 Nov 13.
11. EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation. Pasonen-Seppanen S, etal., J Invest Dermatol 2003 Jun;120(6):1038-44.
12. GOA pipeline RGD automated data pipeline
13. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
14. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
15. Comprehensive gene review and curation RGD comprehensive gene curation
16. Changed lamellipodial extension, adhesion plaques and migration in epidermal keratinocytes containing constitutively expressed sense and antisense hyaluronan synthase 2 (Has2) genes. Rilla K, etal., J Cell Sci. 2002 Sep 15;115(Pt 18):3633-43.
17. The effect of hyaluronic acid size and concentration on branching morphogenesis and tubule differentiation in developing kidney culture systems: potential applications to engineering of renal tissues. Rosines E, etal., Biomaterials. 2007 Nov;28(32):4806-17. Epub 2007 Aug 15.
18. Renal hyaluronan content during experimental uncontrolled diabetes in rats. Rugheimer L, etal., J Physiol Pharmacol. 2008 Mar;59(1):115-28.
19. Hyaluronan synthases and hyaluronidases in the kidney during changes in hydration status. Rugheimer L, etal., Matrix Biol. 2009 Sep;28(7):390-5. doi: 10.1016/j.matbio.2009.07.002. Epub 2009 Jul 25.
20. Involvement of hyaluronan synthesis in ovarian follicle growth in rats. Takahashi N, etal., Reproduction. 2013 Dec 19;147(2):189-97. doi: 10.1530/REP-13-0464. Print 2014 Feb.
21. Tentative Sequence Identification Numbers Tentative Sequence Data IDs. TIGR Gene Index, Rat Data
22. Use of suppression subtractive hybridization for differential gene expression in stroke: discovery of CD44 gene expression and localization in permanent focal stroke in rats. Wang H, etal., Stroke. 2001 Apr;32(4):1020-7.
23. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. Yokoyama U, etal., J Clin Invest. 2006 Nov;116(11):3026-34.
Additional References at PubMed
PMID:10455188   PMID:10930438   PMID:12784612   PMID:14506240   PMID:15722343   PMID:17324121   PMID:17451373   PMID:17989988   PMID:18834074   PMID:19393425   PMID:20522558   PMID:21246657  
PMID:21551265   PMID:22016393   PMID:22383528   PMID:23645665   PMID:24057227   PMID:25499520   PMID:25795779  


Comparative Map Data
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
mRatBN7.2788,113,326 - 88,139,337 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl788,113,326 - 88,128,933 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx789,997,804 - 90,023,812 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0792,199,040 - 92,225,048 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0792,001,677 - 92,027,674 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.0796,438,046 - 96,464,049 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl796,438,046 - 96,464,049 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.0797,055,458 - 97,081,461 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.4793,230,135 - 93,256,139 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.1793,264,364 - 93,290,369 (-)NCBI
Celera784,901,996 - 84,927,998 (-)NCBICelera
RH 3.4 Map7607.6RGD
Cytogenetic Map7q33NCBI
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
GRCh388121,612,116 - 121,641,440 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl8121,612,116 - 121,641,440 (-)EnsemblGRCh38hg38GRCh38
GRCh378122,624,356 - 122,653,680 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 368122,694,719 - 122,722,811 (-)NCBINCBI36Build 36hg18NCBI36
Build 348122,694,720 - 122,722,811NCBI
Celera8118,814,049 - 118,842,240 (-)NCBICelera
Cytogenetic Map8q24.13NCBI
HuRef8117,950,042 - 117,978,400 (-)NCBIHuRef
CHM1_18122,665,454 - 122,693,813 (-)NCBICHM1_1
T2T-CHM13v2.08122,742,348 - 122,771,670 (-)NCBIT2T-CHM13v2.0
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
GRCm391556,529,023 - 56,557,942 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl1556,529,023 - 56,557,935 (-)EnsemblGRCm39 Ensembl
GRCm381556,665,627 - 56,694,546 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl1556,665,627 - 56,694,539 (-)EnsemblGRCm38mm10GRCm38
MGSCv371556,497,182 - 56,526,101 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv361556,495,712 - 56,524,587 (-)NCBIMGSCv36mm8
Celera1558,189,438 - 58,218,384 (-)NCBICelera
Cytogenetic Map15D1NCBI
cM Map1523.31NCBI
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
ChiLan1.0 EnsemblNW_004955540593,316 - 609,865 (-)EnsemblChiLan1.0
ChiLan1.0NW_004955540593,316 - 609,760 (-)NCBIChiLan1.0ChiLan1.0
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
NHGRI_mPanPan18114,560,317 - 114,589,433 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v08118,313,186 - 118,342,160 (-)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.18121,073,419 - 121,101,450 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl8121,072,154 - 121,089,365 (-)Ensemblpanpan1.1panPan2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
CanFam3.11320,310,946 - 20,342,647 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl1320,309,872 - 20,341,636 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha1320,341,670 - 20,392,564 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.01320,646,614 - 20,697,736 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl1320,647,874 - 20,664,774 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.11320,379,420 - 20,429,051 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.01320,482,900 - 20,533,502 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.01320,720,804 - 20,770,669 (-)NCBIUU_Cfam_GSD_1.0
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
HiC_Itri_2NW_02440530317,991,598 - 18,018,681 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_00493647025,418,063 - 25,444,634 (+)EnsemblSpeTri2.0SpeTri2.0 Ensembl
SpeTri2.0NW_00493647025,418,069 - 25,443,332 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
Sscrofa11.1 Ensembl417,596,492 - 17,615,480 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1417,583,154 - 17,613,524 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.2418,458,703 - 18,489,076 (-)NCBISscrofa10.2Sscrofa10.2susScr3
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
ChlSab1.18116,199,516 - 116,228,705 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl8116,200,799 - 116,228,788 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366603924,042,921 - 24,072,107 (+)NCBIVero_WHO_p1.0Vero_WHO_p1.0
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
HetGla_female_1.0 EnsemblNW_00462473533,095,515 - 33,121,237 (+)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_00462473533,095,441 - 33,121,030 (+)NCBIHetGla_female_1.0HetGla 1.0hetGla2


Variants in Has2
54 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:825
Count of miRNA genes:318
Interacting mature miRNAs:408
Prediction methods:Microtar, Miranda
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
634336Anxrr17Anxiety related response QTL 173.66locomotor behavior trait (VT:0001392)number of entries into a discrete space in an experimental apparatus (CMO:0000960)7924703115097879Rat
1643004Pain2Pain QTL 21mechanical nociception trait (VT:0002734)self mutilation severity score (CMO:0002145)7946224698011544Rat
61357Bp38Blood pressure QTL 381.60.052arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)741333674119109060Rat
10053722Scort27Serum corticosterone level QTL 272.410.0083blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)74322875088228750Rat
1358361Sradr5Stress Responsive Adrenal Weight QTL 55.55adrenal gland mass (VT:0010420)both adrenal glands wet weight (CMO:0000164)743747012108555253Rat
1300179Kidm5Kidney mass QTL 53.51kidney mass (VT:0002707)left kidney wet weight (CMO:0000083)743747012135012528Rat
1300149Cm6Cardiac mass QTL 64.09heart mass (VT:0007028)heart left ventricle weight to body weight ratio (CMO:0000530)743747099102228765Rat
631504Cm27Cardiac mass QTL 273.45heart left ventricle mass (VT:0007031)heart left ventricle wet weight (CMO:0000071)744421311118198041Rat
61428Scl3Serum cholesterol level QTL 33.2blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)74486753389867533Rat
738030Anxrr8Anxiety related response QTL 84.1exploratory behavior trait (VT:0010471)number of entries into a discrete space in an experimental apparatus (CMO:0000960)74659007091590070Rat
2293696Bmd32Bone mineral density QTL 325.10.0001femur strength trait (VT:0010010)femoral neck polar moment of inertia (CMO:0001670)74765143992651439Rat
2293707Bss32Bone structure and strength QTL 327.640.0001femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)74765143992651439Rat
2300178Bmd54Bone mineral density QTL 545.30.0001femur mineral mass (VT:0010011)volumetric bone mineral density (CMO:0001553)74765143992651439Rat
2293644Bmd29Bone mineral density QTL 295.40.0001femur size trait (VT:1000369)femoral neck cross-sectional area (CMO:0001697)74765143992651439Rat
2293667Bss42Bone structure and strength QTL 427.250.0001lumbar vertebra size trait (VT:0010518)lumbar vertebra cross-sectional area (CMO:0001689)74765143992651439Rat
2293678Bss24Bone structure and strength QTL 246.710.0001femur morphology trait (VT:0000559)femur cross-sectional area (CMO:0001661)74765143992651439Rat
2293685Bmd21Bone mineral density QTL 214.20.0003femur mineral mass (VT:0010011)total volumetric bone mineral density (CMO:0001728)74765143992651439Rat
1300151Bp181Blood pressure QTL 1813.36arterial blood pressure trait (VT:2000000)diastolic blood pressure (CMO:0000005)753612714103945643Rat
2317035Aia16Adjuvant induced arthritis QTL 162.71joint integrity trait (VT:0010548)right rear ankle joint diameter (CMO:0002150)759238038104238038Rat
1298528Bp169Blood pressure QTL 1690.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)761074194106074194Rat
1559283Emca4Estrogen-induced mammary cancer QTL 43.7mammary gland integrity trait (VT:0010552)percentage of study population developing mammary tumors during a period of time (CMO:0000948)762004452101773158Rat
1576303Ept7Estrogen-induced pituitary tumorigenesis QTL 73.7pituitary gland mass (VT:0010496)pituitary gland wet weight (CMO:0000853)762004452101773158Rat
70173Niddm19Non-insulin dependent diabetes mellitus QTL 194.330.00005blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)764002457135012528Rat
2316947Rf58Renal function QTL 587.8kidney glomerulus morphology trait (VT:0005325)index of glomerular damage (CMO:0001135)768938720113886318Rat
2316952Pur22Proteinuria QTL 225.2urine protein amount (VT:0005160)urine protein level (CMO:0000591)768938720113886318Rat
2316955Stl24Serum triglyceride level QTL 247.1blood triglyceride amount (VT:0002644)plasma triglyceride level (CMO:0000548)768938720113886318Rat
631540Bw9Body weight QTL 94.5body mass (VT:0001259)body weight (CMO:0000012)769736226117455174Rat
1357338Stl17Serum triglyceride level QTL 173.23blood triglyceride amount (VT:0002644)serum triglyceride level (CMO:0000360)769736356112729554Rat
634331Pia17Pristane induced arthritis QTL 174.7joint integrity trait (VT:0010548)arthritic paw count (CMO:0001460)773829340130221005Rat
7411654Foco25Food consumption QTL 259.30.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)775918751120918751Rat
7411607Foco15Food consumption QTL 150.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)775918751120918751Rat
724537Niddm52Non-insulin dependent diabetes mellitus QTL 520.02blood glucose amount (VT:0000188)blood glucose level area under curve (AUC) (CMO:0000350)78022129993595843Rat
1641908Teswt1Testicular weight QTL 13.28testis mass (VT:1000644)both testes wet weight (CMO:0000175)78022129994811326Rat
631529Tls2T-lymphoma susceptibility QTL 200.001thymus integrity trait (VT:0010555)percentage of study population developing T-cell lymphomas during a period of time (CMO:0001911)780221299109401111Rat
1331746Kidm9Kidney mass QTL 93.934kidney mass (VT:0002707)right kidney wet weight (CMO:0000082)780221299112308525Rat
1331728Bp214Blood pressure QTL 2142.825arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)780221299124373579Rat
1331768Kidm10Kidney mass QTL 104.62096kidney mass (VT:0002707)left kidney wet weight (CMO:0000083)780221299125221299Rat
2317052Aia17Adjuvant induced arthritis QTL 172.13joint integrity trait (VT:0010548)left rear ankle joint diameter (CMO:0002149)781737938126737938Rat
634322Bw12Body weight QTL 120body mass (VT:0001259)body weight (CMO:0000012)783153392128153392Rat
1358891Bp265Blood pressure QTL 2652.21arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)783591953134666232Rat
1358914Bp266Blood pressure QTL 266arterial blood pressure trait (VT:2000000)mean arterial blood pressure (CMO:0000009)783591953134666232Rat
71114Niddm14Non-insulin dependent diabetes mellitus QTL 144.5blood glucose amount (VT:0000188)plasma glucose level (CMO:0000042)784257275129257275Rat
2298475Eau6Experimental allergic uveoretinitis QTL 60.0029uvea integrity trait (VT:0010551)experimental autoimmune uveitis score (CMO:0001504)784257275129257275Rat
1558655Swd4Spike wave discharge measurement QTL 43.680.0002brain electrophysiology trait (VT:0010557)brain spike-and-wave discharge severity grade (CMO:0001988)786983365131983365Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2788,115,795 - 88,116,189 (+)MAPPERmRatBN7.2
Rnor_6.0796,440,516 - 96,440,909NCBIRnor6.0
Rnor_5.0797,057,928 - 97,058,321UniSTSRnor5.0
RGSC_v3.4793,232,605 - 93,232,998UniSTSRGSC3.4
Celera784,904,466 - 84,904,859UniSTS
Cytogenetic Map7q32UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2788,114,706 - 88,114,867 (+)MAPPERmRatBN7.2
Rnor_6.0796,439,427 - 96,439,587NCBIRnor6.0
Rnor_5.0797,056,839 - 97,056,999UniSTSRnor5.0
RGSC_v3.4793,231,516 - 93,231,676UniSTSRGSC3.4
Celera784,903,377 - 84,903,537UniSTS
RH 3.4 Map7607.6UniSTS
Cytogenetic Map7q32UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.2788,115,771 - 88,115,994 (+)MAPPERmRatBN7.2
Rnor_6.0796,440,492 - 96,440,714NCBIRnor6.0
Rnor_5.0797,057,904 - 97,058,126UniSTSRnor5.0
RGSC_v3.4793,232,581 - 93,232,803UniSTSRGSC3.4
Celera784,904,442 - 84,904,664UniSTS
Cytogenetic Map7q32UniSTS

Genetic Models
This gene Has2 is modified in the following models/strains:


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
Medium 10 2 14 16
Low 2 31 24 16 8 16 7 8 60 9 15 7 7
Below cutoff 1 2 27 19 11 19 1 2 12 12 3 4 1


RefSeq Acc Id: ENSRNOT00000006517   ⟹   ENSRNOP00000006517
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl788,113,326 - 88,128,933 (-)Ensembl
Rnor_6.0 Ensembl796,438,046 - 96,464,049 (-)Ensembl
RefSeq Acc Id: NM_013153   ⟹   NP_037285
Rat AssemblyChrPosition (strand)Source
mRatBN7.2788,113,326 - 88,139,337 (-)NCBI
Rnor_6.0796,438,046 - 96,464,049 (-)NCBI
Rnor_5.0797,055,458 - 97,081,461 (-)NCBI
RGSC_v3.4793,230,135 - 93,256,139 (-)RGD
Celera784,901,996 - 84,927,998 (-)RGD
RefSeq Acc Id: NP_037285   ⟸   NM_013153
- UniProtKB: O35776 (UniProtKB/Swiss-Prot),   A6HRH9 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000006517   ⟸   ENSRNOT00000006517
Protein Domains
Glycosyltransferase 2-like

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-O35776-F1-model_v2 AlphaFold O35776 1-552 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13695339
Promoter ID:EPDNEW_R5863
Type:multiple initiation site
Description:hyaluronan synthase 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.0796,464,082 - 96,464,142EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2781 AgrOrtholog
BioCyc Gene G2FUF-33365 BioCyc
Ensembl Genes ENSRNOG00000004854 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
  ENSRNOG00055021708 UniProtKB/Swiss-Prot
  ENSRNOG00060003489 UniProtKB/Swiss-Prot
  ENSRNOG00065015133 UniProtKB/Swiss-Prot
Ensembl Transcript ENSRNOT00000006517 ENTREZGENE
  ENSRNOT00000006517.5 UniProtKB/Swiss-Prot
  ENSRNOT00055037174 UniProtKB/Swiss-Prot
  ENSRNOT00060005727 UniProtKB/Swiss-Prot
  ENSRNOT00065025052 UniProtKB/Swiss-Prot
InterPro Glyco_trans_2-like UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Nucleotide-diphossugar_trans UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:25694 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam Chitin_synth_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Glycos_transf_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Has2 PhenoGen
RatGTEx ENSRNOG00000004854 RatGTEx
  ENSRNOG00055021708 RatGTEx
  ENSRNOG00060003489 RatGTEx
  ENSRNOG00065015133 RatGTEx
Superfamily-SCOP Nucleotide-diphospho-sugar transferases UniProtKB/TrEMBL, UniProtKB/Swiss-Prot
TIGR TC208915

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2002-06-10 Has2  Hyaluronan synthase 2      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_regulation mRNA is upregulated by epidermal growth factor, downregulated by transforming growth factor beta 708315